TAGRISSO (Osimertinib) in NSCLC Patients in Whom T790 Mutations Are Detected by Liquid Biopsy
Clinical trial NCT03394118 · COMPLETED
Trial details
- NCT number
- NCT03394118
- Sponsor
- Asan Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-11
- Primary completion
- 2021-03-11
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.